131I-MIBG

Known as: 131 I-MIBG, (131)I-MIBG, I-131 MIBG 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2017
02419832017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
PURPOSE to compare lesion detectability of I-123 MIBG scintigraphy with that of high-dose I-131 MIBG and to evaluate incremental… (More)
  • table 2
  • table 3
  • table 4
  • figure 1
  • figure 2
Is this relevant?
2005
2005
Radionuclide imaging has proven to be very useful when dealing with neuroendocrine tumors and several radiotracers are currently… (More)
Is this relevant?
1992
1992
Iodine-131 metaiodobenzylguanidine (MIBG) has shown effectiveness as a systemic radiotherapeutic agent in neuroblastoma. The… (More)
Is this relevant?
1989
1989
Fourteen children with histopathologically confirmed neuroblastoma underwent sequential correlative imaging studies using I-131… (More)
Is this relevant?
1987
1987
To ascertain the magnetic resonance (MR) imaging characteristics of pheochromocytomas and paragangliomas and to compare MR with… (More)
Is this relevant?
1986
1986
I-131 metaiodobenzylguanidine (I-131 MIBG) is a well established imaging agent that reliably detects pheochromocytoma. In some… (More)
Is this relevant?
1985
1985
The radiopharmaceutical iodine 131 metaiodobenzylguanidine (I-131 MIBG) has been shown to locate pheochromocytomas… (More)
Is this relevant?
1984
1984
Apart from relieving effects of secreted catecholamines, treatments of malignant pheochromocytoma have achieved little success… (More)
Is this relevant?
Highly Cited
1983
Highly Cited
1983
The scintigraphic distribution of m-[131I]iodobenzylguanidine (I-131 MIBG), an adrenal medullary imaging agent, was studied to… (More)
Is this relevant?
1983
1983
Heart intensity (HI) in the 24- and 48-hr images of meta-[131I]iodobenzylguanidine (I-131 MIBG), a pheochromocytoma-seeking… (More)
Is this relevant?